Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients With Multiple Myeloma With Extramedullary Disease or Plasma Cell Leukemia

NCT02547662 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02547662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02547662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients With Multiple Myeloma With Extramedullary Disease or Plasma Cell Leukemia
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
December 24, 2015
Completion date
October 30, 2020
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

plasma cell leukemia, plasma cell myeloma, plasmacytoma